GFRAL Is Widely Distributed in the Brain and Peripheral Tissues of Mice

• Published in: Nutrients Vol. 16; no. 5; p. 734
• Main Authors: Fichtner, Karoline, Kalwa, Hermann, Lin, Miao-Miao, Gong, Yuanyuan, Müglitz, Anne, Kluge, Michael, Krügel, Ute
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 04.03.2024; MDPI
• Subjects: Animals; Anorexia; Antibodies; body image; Body weight; Body Weight - physiology; Brain; brain stem; cachexia; Cachexia - metabolism; Cancer; Cytokines; Eating disorders; Food; food intake; Gender differences; Glial Cell Line-Derived Neurotrophic Factor Receptors - metabolism; hippocampus; Humans; immunohistochemistry; kidneys; Kinases; Liver; Medical research; Metabolism; Mice; muscles; obesity; Obesity - metabolism; prefrontal cortex; Proteins; Sheep; small intestine; Software; Solitary Nucleus - metabolism; Type 2 diabetes; Weight control; United Kingdom; Germany; United States > US; peripheral tissue; immunohistochemistry; brain; GFRAL
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu16050734

In 2017, four independent publications described the glial cell-derived neurotrophic factor (GDNF) receptor alpha-like (GFRAL) as receptor for the growth differentiation factor 15 (GDF15, also MIC-1, NAG-1) with an expression exclusively in the mice brainstem area postrema (AP) and nucleus tractus solitarii (NTS) where it mediates effects of GDF15 on reduction of food intake and body weight. GDF15 is a cell stress cytokine with a widespread expression and pleiotropic effects, which both seem to be in contrast to the reported highly specialized localization of its receptor. This discrepancy prompts us to re-evaluate the expression pattern of GFRAL in the brain and peripheral tissues of mice. In this detailed immunohistochemical study, we provide evidence for a more widespread distribution of this receptor. Apart from the AP/NTS region, GFRAL-immunoreactivity was found in the prefrontal cortex, hippocampus, nucleus arcuatus and peripheral tissues including liver, small intestine, fat, kidney and muscle tissues. This widespread receptor expression, not taken into consideration so far, may explain the multiple effects of GDF-15 that are not yet assigned to GFRAL. Furthermore, our results could be relevant for the development of novel pharmacological therapies for physical and mental disorders related to body image and food intake, such as eating disorders, cachexia and obesity.